Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enfuvirtide intensification in HIV
NCT00487188Phase 4Completed
- Sponsor
- Roche
- Start
- Nov 2005
- Primary completion
- Nov 2007
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
Phase 4, randomised, open-label trial of enfuvirtide in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Roche. Primary endpoint: Number of Participants With Viral Suppression: HIV-1 RNA < 50 Copies/mL at 24 weeks. Started Nov 2005; status: completed.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00487188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00487188.